Revenue Growth Across Segments
Revenue increased by 5% year over year, with the medical segment growing by 3% and the industrial segment by 10%.
Improved Gross Margin
Non-GAAP gross margin increased to 35%, up from 31% in the same quarter last year, aided by product sales mix and productivity gains.
Strong Cash Management
Cash from operations was $10 million for the quarter, with cash, cash equivalents, and marketable securities totaling $219 million, up $6 million from fiscal 2024 year-end.
China Sales Improvement
Sales in China increased by 7% year over year and 12% sequentially, accounting for 18% of total sales.
Security Inspection Orders
Received additional orders from industrial customers valued at approximately $14 million for cargo inspection systems, contributing to long-term growth opportunities.